Physician profile
Karli King
NPI 1477027175
$2,054.64
in general payments reported to CMS, 2019-2025
16 companies · $28.13 in 2025
The $28.13 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $540 · 2023: $426 · 2024: $363 · 2025: $28.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $653.44 | 2021-2022 | |
| Corcept Therapeutics | $342.22 | 2022-2023 | Korlym |
| Astrazeneca Pharmaceuticals LP | $236.74 | 2021 | |
| Lilly USA, LLC | $130.17 | 2022-2024 | |
| Kyowa Kirin, INC. | $124.99 | 2023 | Crysvita |
| Cequr Corporation | $94.31 | 2024 | Cequr Simplicity |
| Medtronic, INC. | $87.17 | 2023-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Insulet Corporation | $85.18 | 2022 | |
| Abbott Laboratories | $64.71 | 2021-2024 | Freestyle Libre 3 |
| Alexion Pharmaceuticals, INC. | $52.27 | 2024 | Strensiq |
| Xeris Pharmaceuticals, INC. | $47.74 | 2024 | Recorlev |
| Dexcom, INC. | $44.93 | 2023 | Dexcom G6 Transmitter |
| Lexicon Pharmaceuticals, INC. | $28.95 | 2024 | |
| Baxter Healthcare | $28.13 | 2025 | Tisseel |
| Amgen INC. | $18.16 | 2024 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karli King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.